|
1. MEDICINAL PRODUCT FOR HUMANS, PACKAGED FOR RETAIL SALE. SERIES 8317C: FRAXIPARIN«, SOLUTION FOR INJECTION, 9500 IU ANTI-XA/ML, 0.4 ML (3800 IU ANTI-XA) IN PREFILLED SYRINGE, 2 SYRINGES IN A BLISTER; 5 BLISTERS IN A CARDBOARD BOX - 100 PACKS. (ACTIVE SUBSTANCE - NADROPARIN CALCIUM) MANUFACTURER: ASPEN NOTRE DAME DE BONDEVILLE, FR.
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. MEDICINES FOR HUMANS, WITHOUT THE CONTENT OF: ANTIBIOTICS, ALKALOIDS, HORMONES, VITAMINS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: MARKAIN SPINAL HEAVY, SOLUTION FOR INJECTION, 5 MG/ML, 4 ML IN AN AMPOULE; 5 AMPOULES EACH IN A CONTOURED BLISTER PACK; PER 1 CONTOUR BLISTER PACK IN A CARDBOARD BOX / 1 ML OF SOLUTION CONTAINS BUPIVACAINE HYDROCHLORIDE MONOHYDRATE 5.28 MG IN TERMS OF BUPIVACAINE HYDROCHLORIDE 5 MG; MANUFACTURER SENEXI, FRANCE; FRAXIPARIN ®, SOLUTION FOR INJECTION, 9500 IU ANTI-XA/ML; 0.3 ML EACH (2850 IU OF ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS IN A BOX / 1 ML OF SOLUTION CONTAINS 9500 IU OF ANTI-XA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.3 ML) CONTAINS 2850 IU OF ANTI-XA NADROPARIN CALCIUM; MANUFACTURER ASPEN NOTRE DAME DE BONDEVILLE, FRANCE; FRAXIPARIN ®, SOLUTION FOR INJECTION, 9500 IU ANTI-XA/ML; 0.4 ML EACH (3800 IU ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS IN A BOX / 1 ML SOLUTION CONTAINS 9500 IU ANTI-XA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.3 ML) CONTAINS 2850 IU ANTI-XA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.4 ML) CONTAINS 3800 IU ANTI-XA NADROPARIN CALCIUM; MANUFACTURER ASPEN NOTRE DAME DE BONDEVILLE, FRANCE;"""
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. MEDICINES FOR HUMANS, PACKAGED FOR RETAIL SALE. SERIES 8418B: FRAXIPARIN®, SOLUTION FOR INJECTION, 9500 IU ANTI-XA/ML, 0.3 ML (2850 IU ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS IN A CARDBOARD BOX - 3329 PACKS. (ACTIVE SUBSTANCE - NADROPARIN CALCIUM) MANUFACTURER: ASPEN NOTRE DAME DE BONDEVILLE, FR."""
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. MEDICINES FOR HUMANS, PACKAGED FOR RETAIL TRADE. SERIES F0388-1: MARKAIN SPINAL HEAVY, SOLUTION FOR INJECTION 5 MG/ML, 4 ML IN AN AMPOULE; 5 AMPOULES EACH IN A CONTOURED BLISTER PACK; ON 1 CONTOUR ENVELOPE IN A CARDBOARD BOX - 100 PACKS. (ACTIVE SUBSTANCE - BUPIVACAINE HYDROCHLORIDE MONOHYDRATE) MANUFACTURER: SENEXI, FR. SERIES 8317C: FRAXIPARIN®, SOLUTION FOR INJECTION, 9500 IU ANTI-XA/ML, 0.4 ML (3800 IU ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS IN A CARDBOARD BOX - 60 PACKS. SERIES 8329: FRAXIPARIN®, SOLUTION FOR INJECTIONS, 9500 IU ANTI-XA/ML, 0.6 ML (5700 IU ANTI-XA) IN AN ALTERNATELY FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS IN A CARDBOARD BOX - 60 PACKS (ACTIVE SUBSTANCE - NADROPARIN CALCIUM) MANUFACTURER: ASPEN NOTRE DAME DE BONNEVILLE, FR."""
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. DRUGS FOR HUMANS, NOT CONTAINING: ANTIBIOTICS, ALKALOIDS, HORMONES, VITAMINS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ARIXTRA ® SOLUTION FOR INJECTION, 2.5 MG/0.5 ML IN 0.5 ML PRE-FILLED SYRINGE; 10 SYRINGES IN A CARDBOARD BOX / 1 SYRINGE (0.4 ML) CONTAINS 5 MG OF FONDAPARINUX SODIUM; MANUFACTURED BY ASPEN NOTRE DAME DE BONDEVILLE, FRANCE; FRAXIPARIN ® SOLUTION FOR INJECTION, 9500 IU ANTI-HA/ML; 0.3 ML EACH (2850 IU ANTI-HA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN BLISTERS; 5 BLISTERS IN A BOX / 1 ML SOLUTION CONTAINS 9500 IU ANTI-HA NUPROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.3 ML) CONTAINS 2850 IU ANTI-HA NUPROPARIN CALCIUM; MANUFACTURED BY ASPEN NOTRE DAME DE BONDEVILLE, FRANCE; FRAXIPARIN ® SOLUTION FOR INJECTION, 9500 IU ANTI-HA/ML; 0.4 ML EACH (3800 IU ANTI-HA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN BLISTERS; 5 BLISTERS IN A BOX / 1 ML SOLUTION CONTAINS 9500 IU ANTI-HA NUPROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.3 ML) CONTAINS 2850 IU ANTI-HA NUPROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.4 ML) CONTAINS 3800 MO ANTI-HA NADROPARIN CALCIUM; MADE BY ASPEN NOTRE DAME DE BONDEVILLE, FRANCE
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. MEDICINES FOR HUMANS, WITHOUT THE CONTENT OF ANTIBIOTICS, ALKALOIDS, HORMONES, VITAMINS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ARIKSTRA ®, SOLUTION FOR INJECTION, 2.5 MG/0.5 ML IN 0.5 ML IN PRE A FILLED SYRINGE; 10 SYRINGES IN A CARDBOARD BOX / 1 SYRINGE (0.4 ML) CONTAINS 5 MG OF FONDAPARINUX SODIUM; MANUFACTURER ASPEN NOTRE DAME DE BONDEVILLE, FRANCE; MARKAIN SPINAL HEAVY, SOLUTION FOR INJECTION, 5 MG/ML, 4 ML IN AN AMPOULE ; 5 AMPOULES EACH IN A CONTOURED BLISTER PACK; PER 1 CONTOUR BLISTER PACK IN A CARDBOARD BOX / 1 ML OF SOLUTION CONTAINS BUPIVACAINE HYDROCHLORIDE MONOHYDRATE 5.28 MG IN TERMS OF BUPIVACAINE HYDROCHLORIDE 5 MG; MANUFACTURER SENEXY, FRANCE; FRAXIPARIN ®, SOLUTION FOR INJECTION, 9500 IU ANTI-XA/ML; 0.3 ML EACH (2850 IU OF ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS IN A BOX / 1 ML SOLUTION CONTAINS 9500 IU ANTI-XA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.3 ML) CONTAINS 2850 IU ANTI-XA NADROPARIN CALCIUM; MANUFACTURER ASPEN NOTRE DAME DE BONDEVILLE, FRANCE;"""
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. DRUGS FOR HUMANS, NOT CONTAINING: ANTIBIOTICS, ALKALOIDS, HORMONES, VITAMINS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ARIXTRA ® SOLUTION FOR INJECTION, 2.5 MG/0.5 ML IN 0.5 ML PRE-FILLED SYRINGE; 10 SYRINGES IN A CARDBOARD BOX / 1 SYRINGE (0.4 ML) CONTAINS 5 MG OF FONDAPARINUX SODIUM; MANUFACTURED BY ASPEN NOTRE DAME DE BONDEVILLE, FRANCE; MARCAINE, SOLUTION FOR INJECTION, 5 MG/ML IN 20 ML VIAL; 5 VIALS IN A CARTON / 1 ML OF SOLUTION CONTAINS BUPIVACAIN HYDROCHLORIDE MONOHYDRATE AS BUPIVACAIN HYDROCHLORIDE 5 MG; MANUFACTURER RECIPHARM MONTS, FRANCE; MARKAIN SPINAL HEAVY, SOLUTION FOR INJECTION, 5 MG/ML, 4 ML IN AMPOULE; 5 AMPOULES IN CONTOUR PACKAGING; PER 1 CONTOUR BLISTER IN A CARDBOARD BOX / 1 ML OF SOLUTION CONTAINS BUPIVACAIN HYDROCHLORIDE MONOHYDRATE 5.28 MG AS BUPIVACAIN HYDROCHLORIDE 5 MG; MANUFACTURER SENEXI, FRANCE; FRAXIPARIN ®, SOLUTION FOR INJECTION, 9500 IU ANTI-HA/ML; 0.4 ML EACH (3800 IU ANTI-HA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN BLISTERS; 5 BLISTERS IN A BOX / 1 ML SOLUTION CONTAINS 9500 IU ANTI-HA NADRAPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.3 ML) CONTAINS 2850 IU ANTI-HA NADRAPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.4 ML) CONTAINS T 3800 MO ANTI-HA NADROPARIN CALCIUM; MADE BY ASPEN NOTRE DAME DE BONDEVILLE, FRANCE
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. DRUGS FOR HUMANS, NOT CONTAINING: ANTIBIOTICS, ALKALOIDS, HORMONES, VITAMINS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ARIXTRA ® SOLUTION FOR INJECTION, 2.5 MG/0.5 ML IN 0.5 ML PRE-FILLED SYRINGE; 10 SYRINGES PER CARTON / 1 SYRINGE (0.4 ML) CONTAINS 5 MG OF FONDAPARINUX SODIUM; MANUFACTURED BY ASPEN NOTRE DAME DE BONDEVILLE, FRANCE; FRAXIPARIN ® SOLUTION FOR INJECTION, 9500 IU ANTI-HA/ML; 0.4 ML EACH (3800 IU ANTI-HA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN BLISTERS; 5 BLISTERS IN A BOX / 1 ML OF SOLUTION CONTAINS 9500 IU ANTI-HA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.3 ML) CONTAINS 2850 IU ANTI-HA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.4 ML) CONTAINS 3800 IU ANTI-HA NAPROPARIN CALCIUM; MANUFACTURED BY ASPEN NOTRE DAME DE BONDEVILLE, FRANCE
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. MEDICINE FOR HUMAN USE, PACKAGED FOR RETAIL. SERIES 0169: ARIXTRA®, SOLUTION FOR INJECTION, 2.5 MG/0.5 ML, 0.5 ML IN PRE-FILLED SYRINGE; 10 SYRINGES IN A CARDBOARD BOX - 55 UNITS SERIES 0146: ARIKSTRA®, SOLUTION FOR INJECTION, 2.5 MG/0.5 ML, 0.5 ML IN A PRE-FILLED SYRINGE; 10 SYRINGES IN A CARTON BOX - 71 ACTIVE INGREDIENT - FONDAPARINUX SODIUM) SERIES 8329:FRAXIPARIN®, SOLUTION FOR INJECTION, 9500 IU ANTI-HA/ML, 0.6 ML EACH (5700 IU ANTI-HA) IN PRE FILLED SYRINGE; 2 SYRINGES IN BLISTERS; 5 BLISTERS IN A CARDBOARD BOX - 60 PACK. (ACTIVE INGREDIENT - NADROPARIN CALCIUM) MANUFACTURER: ASPEN NOTRE DAME DE BONNVILLE, FR. SERIES F0388-1: MARCAINE SPINAL HEAVY, SOLUTION FOR INJECTION, 5 MG/ML, 4 ML IN AMPOULE; 5 AMPOULES IN CONTOUR PACKAGING; 1 CONTOUR PACKAGE IN A CARDBOARD BOX - 100 PACK. (ACTIVE INGREDIENT - BUPIVACAIN HYDROCHLORIDE MONOG) MANUFACTURER: SENEXI, FR
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. MEDICINAL PRODUCTS FOR HUMANS, FOR THERAPEUTIC USE, PACKAGED FOR RETAIL SALE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. FRAXIPARIN® SOLUTION FOR INJECTION, 9500 IU ANTI- HA/ML; 0.3 ML EACH (2850 IU OF ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS PER BOX / 1 ML SOLUTION CONTAINS 9500 IU ANTI-XA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.4 ML) CONTAINS 3800 IU ANTI-XA NADROPARIN CALCIUM / ASPEN NOTRE DAME DE BONDEVILLE, FRANCE MARCAINE SPINAL HEAVY SOLUTION FOR OTHER EKTION, 5 MG/ML, 4 ML IN AN AMPOULE; 5 AMPOULES EACH IN A CONTOURED BLISTER PACK; ON 1 CONTOUR BLISTER PACKAGE IN A CARDBOARD BOX/1 ML OF SOLUTION CONTAINS BUPIVACAINE HYDROCHLORIDE MONOHYDRATE 5.28 MG IN TERMS OF BUPIVACAINE HYDROCHLORIDE 5 MG/SENEXY, FRANCE"""
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. MEDICINES FOR HUMANS, WITHOUT THE CONTENT OF: ANTIBIOTICS, ALKALOIDS, HORMONES, VITAMINS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ARIKSTRA ®, SOLUTION FOR INJECTION, 2.5 MG/0.5 ML IN 0.5 ML PRE-FILLED SYRINGE; 10 SYRINGES IN A CARDBOARD BOX / 1 SYRINGE (0.4 ML) CONTAINS 5 MG FONDAPARINUX SODIUM; MANUFACTURER ASPEN NOTRE DAME DE BONDEVILLE, FRANCE; MARKAIN SPINAL HEAVY, SOLUTION FOR INJECTION, 5 MG/ML, 4 ML IN AMPOULE; 5 AMPOULES EACH IN A CONTOURED BLISTER PACK; PER 1 CONTOUR BLISTER PACK IN A CARDBOARD BOX / 1 ML OF SOLUTION CONTAINS BUPIVACAINE HYDROCHLORIDE MONOHYDRATE 5.28 MG IN TERMS OF BUPIVACAINE HYDROCHLORIDE 5 MG; MANUFACTURER SENEXI, FRANCE; FRAXIPARIN ®, SOLUTION FOR INJECTION, 9500 IU ANTI-XA/ML; 0.3 ML EACH (2850 IU OF ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS IN A BOX / 1 ML OF SOLUTION CONTAINS 9500 IU OF ANTI-XA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.3 ML) CONTAINS 2850 IU OF ANTI-XA NADROPARIN CALCIUM; MANUFACTURER ASPEN NOTRE DAME DE BONDEVILLE, FRANCE; FRAXIPARIN ®, SOLUTION FOR INJECTION, 9500 IU ANTI-XA/ML; 0.4 ML EACH (3800 IU ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS IN A BOX / 1 ML SOLUTION CONTAINS 9500 IU ANTI-XA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.3 ML) CONTAINS 2850 IU ANTI-XA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.4 ML) CONTAINS 3800 IU ANTI-XA NADROPARIN CALCIUM; MANUFACTURER ASPEN NOTRE DAME DE BONDEVILLE, FRANCE;"""
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. MEDICINAL PRODUCTS FOR HUMANS, FOR THERAPEUTIC USE, PACKAGED FOR RETAIL SALE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. FRAXIPARIN® SOLUTION FOR INJECTION, 9500 IU ANTI- HA/ML; 0.3 ML EACH (2850 IU OF ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS PER BOX / 1 ML SOLUTION CONTAINS 9500 IU ANTI-XA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.4 ML) CONTAINS 3800 IU ANTI-XA NADROPARIN CALCIUM / ASPEN NOTRE DAME DE BONDEVILLE, FRANCE FRAXIPARIN® SOLUTION FOR INJECTION , 9500 IU ANTI-XA/ML; 0.4 ML EACH (3800 IU ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS PER BOX/1 ML SOLUTION CONTAINS 9500 IU ANTI-XA NADROPARIN CALCIUM; 1 PRE-FILLED SYRINGE (0.4 ML) CONTAINS 3800 IU ANTI-XA NADROPARIN CALCIUM/ASPEN NOTRE DAME DE BONDEVILLE, FRANCE ARIXTRA® SOLUTION FOR INJECTION , 2.5 MG/0.5 ML OF 0.5 ML IN A PRE-FILLED SYRINGE; 10 SYRINGES IN A CARDBOARD BOX / 1 SYRINGE (0.5 ML) CONTAINS 2.5 MG FONDAPARINUX SODIUM / ASPEN NOTRE DAME DE BONDEVILLE, FRANCE"""
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. MEDICINAL PRODUCTS FOR HUMANS, FOR THERAPEUTIC USE, PACKAGED FOR RETAIL SALE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. FRAXIPARIN« SOLUTION FOR INJECTION, 9500 IU ANTI- HA/ML; 0.4 ML EACH (3800 IU ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS PER BOX/1 ML SOLUTION CONTAINS 9500 IU ANTI-XA NADROPARIN CALCIUM;/1 PRE-FILLED SYRINGE (0.4 ML) CONTAINS 3800 IU ANTI-XA NADROPARIN CALCIUM/ASPEN NOTRE DAME DE BONDEVILLE, FRANCE
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. MEDICINES FOR HUMANS, PACKAGED FOR RETAIL TRADE. SERIES F0388-1: MARKAIN SPINAL HEAVY, SOLUTION FOR INJECTION 5 MG/ML, 4 ML IN AN AMPOULE; 5 AMPOULES EACH IN A CONTOURED BLISTER PACK; ON 1 CONTOUR ENVELOPE IN A CARDBOARD BOX - 200 PACKS. (ACTIVE SUBSTANCE - BUPIVACAINE HYDROCHLORIDE MONOG) MANUFACTURER: SENEXI, FR. SERIES 8317C: FRAXIPARIN«, SOLUTION FOR INJECTION, 9500 IU ANTI-XA/ML, 0.4 ML (3800 IU ANTI-XA) IN A PRE-FILLED SYRINGE ; 2 SYRINGES IN A BLISTER; 5 BLISTERS IN A CARDBOARD BOX - 35 PACKS. SERIES 8246: FRAXIPARIN«, SOLUTION FOR INJECTIONS 9500 IU ANTI-XA/ML, 0.4 ML (3800 IU ANTI-XA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN A BLISTER; 5 BLISTERS IN A CARDBOARD BOX - 55 PACKS (ACTIVE SUBSTANCE - NADROPARIN CALCIUM) MANUFACTURER: ASPEN NOTRE DAME DE BONNEVILLE, FR.
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |
|
1. MEDICINES FOR HUMAN USE, PACKAGED FOR RETAIL TRADE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. FRAXIPARIN® SOLUTION FOR INJECTIONS, 9500 IU ANTI- XA/ML; EACH 0.6 ML (5700 IU ANTI-HA) IN A PRE-FILLED SYRINGE; 2 SYRINGES IN BLISTERS; 5 BLISTERS IN A CARTON; 1 PRE-FILLED SYRINGE (0.6 ML) CONTAINING 5700 IU ANTI-HA NADROPARIN CALCIUM/ASPEN NOTRE DAME DE BONDEVILLE, FRANCE
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
FRANCE |
UKRAINE |
0 |